“Dapagliflozin and Urinary Tract Infection Risk in Type 2 Diabetes: A Comprehensive Critical Review of Mechanistic, Randomized, and Real-World Evidence”. 2026. Tropical Journal of Pharmaceutical and Life Sciences 13 (5): 53-68. https://doi.org/10.61280/9h681f91.